Company profile
Camp4 Therapeutics Corp
NASDAQ:CAMPBiotechnology: Pharmaceutical Preparations
Clinical trials (1)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT06247670 | phase1 | active_not_recruiting | 2024-02-05 | 2027-12-01 | CAMP4 Therapeutics Corporation | Study of CMP-CPS-001 in Healthy Volunteers and Participants With Abnormal Heterozygous OTC Genotype |
FDA applications (0)
No records yet.